公司资料
Viracta Therapeutics 股价、新闻与催化剂
- 股票代码:
- VIRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for VIRX.
公司概览
业务概览
Viracta Therapeutics is an oncology company focused on virus-associated cancers and targeted cancer biology. Its platform aims to treat tumors linked to latent viral drivers.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Viracta sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, target differentiation, and the ability to build a focused oncology franchise.
生物医药行业定位
Viracta is a catalyst-sensitive oncology name whose stock reacts to early clinical and strategic updates.
未来催化剂
- Viracta’s catalysts are nanatinostat-based programs in EBV-positive lymphomas and any development update that keeps the antiviral-oncology story alive. The company still needs strong human data.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。